🎉 Exciting News! 🎉 We are thrilled to announce that we have been granted a Canadian patent for our thermostable protein, FGF2-STAB®!
A huge thanks to our talented scientists who made this possible. We're eager to maximize the impact of this game-changing invention.
2
132
Our FGF2-STAB® has been given an interesting redo by Mateusz Krzyscik et al with high potential in regenerative and cancer medicine including wound healing, anticancer therapy (FGF2-STAB®-based drug carrier) and in diabetes (for patients that cannot be treated with insulin).
74
To start off 2021, we are happy to announce our successful grant application for TACR TREND „Technology Leaders“ programme! Our project was ranked the second one in life science category and 14th all together from the 434 applications. enantis.com/#post-1
1
As a response to the recent coronavirus outbreak, Enantis joined the international efforts and became a member of FASTCURE consortium (fastcure.net/).
The goal of this initiative is to employ structural targeting of coronavirus using repurposing and better diagnostics.
1
This year was full of new opportunities. We are licensing some of our products, developing new molecules and got the ISO certificate for quality. We are looking forward to the new challenges in 2020 and We Wish You a Lovely Christmas Time and a Happy New Year.
This fall, we have an extensive list of conferences to attend (lnkd.in/gzZ4cqU).
The conference season has been kicked off by our Chief Scientific Officer, Radka Chaloupkova, who represented us at the Genetics of Industrial Microorganisms (GIM2019) held in Pisa, Italy.
1
The article summarizing the results of @Enantis’ SME Instrument @EU_H2020 project has been published on @CORDIS_EU website today: cordis.europa.eu/project/rcn….
This piece talks about our motivation to start the project, the results achieved and the experience gained during this period
Today, we had a wonderful coaching session with Antonio Soarez here at Enantis. Antonio provided us with a lot of great insight into our business strategies and marketing, as well as accounting and long-term strategic plans. Thank you very much Antonio.
Our CEO Roman Badik has just presented @Enantis success story with the @H2020SME funding during the European Innovation Council Information Day. Great discussion and we are looking forward to future cooperation with all of the participating stakeholders to help Enantis grow.










